These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 22691890

  • 1. Role of the IGF axis in prostate cancer.
    Biernacka KM, Perks CM, Holly JM.
    Minerva Endocrinol; 2012 Jun; 37(2):173-85. PubMed ID: 22691890
    [Abstract] [Full Text] [Related]

  • 2. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.
    Cancer Res; 1999 May 01; 59(9):2203-9. PubMed ID: 10232609
    [Abstract] [Full Text] [Related]

  • 3. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR.
    J Cell Biochem; 2006 Oct 01; 99(2):392-401. PubMed ID: 16639715
    [Abstract] [Full Text] [Related]

  • 4. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
    Ozkan EE.
    Mol Cell Endocrinol; 2011 Sep 15; 344(1-2):1-24. PubMed ID: 21782884
    [Abstract] [Full Text] [Related]

  • 5. Implications of insulin-like growth factor-I for prostate cancer therapies.
    Kojima S, Inahara M, Suzuki H, Ichikawa T, Furuya Y.
    Int J Urol; 2009 Feb 15; 16(2):161-7. PubMed ID: 19183230
    [Abstract] [Full Text] [Related]

  • 6. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
    Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL, Pollak M.
    Cancer Res; 2001 Aug 15; 61(16):6276-80. PubMed ID: 11507082
    [Abstract] [Full Text] [Related]

  • 7. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
    Liao Y, Abel U, Grobholz R, Hermani A, Trojan L, Angel P, Mayer D.
    Hum Pathol; 2005 Nov 15; 36(11):1186-96. PubMed ID: 16260272
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor ligands, receptors, and binding proteins in cancer.
    Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, Jacobs C, Church D, Hassan AB.
    J Pathol; 2005 Jan 15; 205(2):145-53. PubMed ID: 15641016
    [Abstract] [Full Text] [Related]

  • 12. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
    Miyake H, Pollak M, Gleave ME.
    Cancer Res; 2000 Jun 01; 60(11):3058-64. PubMed ID: 10850457
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2001 May 01; 10(5):421-7. PubMed ID: 11352850
    [Abstract] [Full Text] [Related]

  • 15. The IGF axis in the prostate.
    Cohen P, Peehl DM, Rosenfeld RG.
    Horm Metab Res; 1994 Feb 01; 26(2):81-4. PubMed ID: 8200618
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of the androgen receptor in the development and progression of prostate cancer.
    Jenster G.
    Semin Oncol; 1999 Aug 01; 26(4):407-21. PubMed ID: 10482183
    [Abstract] [Full Text] [Related]

  • 18. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
    Camidge DR, Dziadziuszko R, Hirsch FR.
    Clin Lung Cancer; 2009 Jul 01; 10(4):262-72. PubMed ID: 19632946
    [Abstract] [Full Text] [Related]

  • 19. Insulin-Like Growth Factor (IGF) family and prostate cancer.
    Gennigens C, Menetrier-Caux C, Droz JP.
    Crit Rev Oncol Hematol; 2006 May 01; 58(2):124-45. PubMed ID: 16387509
    [Abstract] [Full Text] [Related]

  • 20. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
    Goel HL, Breen M, Zhang J, Das I, Aznavoorian-Cheshire S, Greenberg NM, Elgavish A, Languino LR.
    Cancer Res; 2005 Aug 01; 65(15):6692-700. PubMed ID: 16061650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.